Characteristic | Freq. | Percentage |
---|---|---|
Socio-demographics | ||
Sex | Â | Â |
Female | 38 | 52.1 |
Male | 35 | 47.9 |
Age | Â | Â |
Mean ± standard deviation (SD) | 53.8 ± 9 |  |
Age categories | Â | Â |
< 45 years | 10 | 13.7 |
45 — 65 years | 55 | 75.3 |
> 65 years | 8 | 11.0 |
Employment status | Â | Â |
No | 15 | 20.6 |
Yes | 58 | 79.5 |
Monthly income* | Â | Â |
Less than 14 USD | 13 | 18.8 |
14–27 USD | 11 | 15.9 |
28–139 USD | 33 | 47.81 |
140–279 USD | 11 | 15.9 |
Above 279 | 1 | 1.4 |
Clinical Characteristics | ||
Body mass index (BMI) | Â | Â |
Normal, 18.5–24.9 kg/m2 | 42 | 58.3 |
Underweight, < 18.5Â kg/m2 | 11 | 15.3 |
Overweight, 25–30 kg/m2 | 15 | 20.8 |
Obese, > 30Â kg/m2 | 4 | 5.6 |
History of smoking | Â | Â |
Yes | 20 | 27.4 |
No | 52 | 71.2 |
Undefined | 1 | 1.4 |
History of Alcohol intake | Â | Â |
Yes | 52 | 71.2 |
No | 20 | 27.4 |
Undefined | 1 | 1.4 |
Viral load | Â | Â |
Detected (> 0 copies/ml) | 19 | 26.0 |
Undetectable (< 0 copies/ml) | 54 | 74.0 |
CD4 count at sample collection | Â | Â |
Less than 500 cells/µl | 38 | 52.1 |
Above 500 cells/µl | 35 | 47.9 |
Duration of ART at sample collection** | Â | Â |
Mean ± SD | 10.4 ± 0.4 |  |
ARV regimen at sample collection (2014/2015) | Â | Â |
ZDV-3TC-NVP | 35 | 48.0 |
ZDV-3TC-EFV | 16 | 22.9 |
TDF-3TC-NVP | 12 | 16.4 |
TDF-3TC-EFV | 3 | 4.1 |
TDF-3TC-ATV/r | 3 | 4.1 |
TDF-3TC-LPV/r | 3 | 4.1 |
TDF-FTC-LPV/r | 1 | 1.4 |
ARV regimen 1 (2004/2005) ** | Â | Â |
d4T (30)-3TC-NVP | 51 | 76.1 |
d4T (40)-3TC-NVP | 14 | 20.9 |
ZDV-3TC-NVP | 1 | 1.5 |
ZDV-3TC-EFV | 1 | 1.5 |
Reason ever switched from first line ** | Â | Â |
Due to new TB | 7 | 10.5 |
MoH recommendation | 40 | 59.7 |
Other (Specify) | 1 | 1.5 |
Pregnancy or risk of pregnancy | 1 | 1.5 |
Toxicity/complications | 16 | 23.9 |
Virologic failure | 2 | 3 |